In tight times companies can see PMI as a luxury. What can an adviser do to counter these thoughts? Alistair Sclare looks at the opposing arguments.
Selling insurance is never easy. Selling private medical insurance when times are tough is even more demanding. Recession intensifies people’s suspicions about the value of an intangible, only-useful-if-something-goes-wrong product. Something like PMI may be seen as a luxury item so when the chips are down, some chief executives and finance directors might understandably conclude that the cost of its premiums cannot be justified, or that in the face of having to make spending cuts, dropping it is the least painful option. The routes to the conclusion are many, but the outcome is the same: m...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes